≡ Menu

Do EDCs have thresholds and can safe exposure values be identified?

There is currently no scientific evidence that can be relied upon to set a threshold value for EDCs with sufficient protective certainty. There has been much public debate about this by key scientists. However, at a meeting with the EU’s Chief Scientific Adviser concerning whether or not there is a threshold level below which exposure to EDCs do not cause harm, consensus was reached that “it is possible that thresholds do not exist” [i].

The Endocrine Society, which is the world’s largest society of leading endocrinologists, argues that for EDCs “it cannot be assumed that there is a threshold” [ii], [iii]. Due to pre-existing endogenous (or natural) hormone levels, any additional exposure to hormone mimicking substances will increase this load in a threshold-independent manner. EDCs exert many different biological effects and many of them are unlikely to have a threshold, in particular when receptor binding is involved [iv].

The Commission’s Joint Research Centre (JRC) has published a meeting report “Thresholds for Endocrine Disrupters and related Uncertainties” which states that most of the experts agreed that thresholds of adversity for EDCs are likely to exist but may be very low or absent during early development [v], [vi].

In this light it seems highly unlikely that safe thresholds could be set with current available methodologies, which was also acknowledged in a recent paper by the EU Commission on the REACH EDC review [vii], [viii].

This page is part of CHEM Trust’s Hormone Disrupting Chemicals FAQ – Full list of questions here.

The next question is “Some people claim the precautionary principle is unscientific, is this true?“.

 

[i]. http://ec.europa.eu/commission_2010-2014/president/chief-scientific-adviser/documents/minutes_endocrine_disruptors_meeting_241013_final.pdf

[ii]. Zoeller et al.: Endocrine-disrupting chemicals and public health protection: a statement of principles from The Endocrine Society, Endocrinology, 153, 9, 2012, 4097-4110. doi:10.1210/en.2012-1422

[iii]. http://press.endocrine.org/doi/full/10.1210/en.2013-1854

[iv]. Ulla Hass et al, Centre on Endocrine Disruptors, DTU, National Food Institute: Input for the REACH-review in 2013 on endocrine disruptors, 2013. http://www.mst.dk/NR/rdonlyres/54DB4583-B01D-45D6-AA99-28ED75A5C0E4/154979/ReachreviewrapportFINAL21March.pdf

[v]. JRC report: Thresholds for Endocrine Disrupters and related Uncertainties, Report of the ED expert Advisory Group, published August 2014 http://ihcp.jrc.ec.europa.eu/our_activities/food-cons-prod/endocrine_disrupters/jrc-publishes-report-ed/

[vi]http://www.chemtrust.org.uk/do-endocrine-disrupting-chemicals-edcs-have-a-safe-limit/

[vii]http://chemicalwatch.com/20512/eu-commission-finishes-reach-edc-review

[viii]. CHEM Trust Briefing on REACH EDC review: http://www.chemtrust.org.uk/wp-content/uploads/CHEM-Trust-Briefing-on-REACH-EDC-review-FINAL.pdf